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Background: The aim of the current study was to analyze the impact of single versus double 
transseptal puncture (TSP) for atrial fibrillation (AF) ablation. 
Methods: Consecutive patients undergoing AF ablation were prospectively included in the 
AF ablation registry and were analyzed according to single versus double TSP. 
Results: A total of 478 patients (female 35%, persistent AF 67%) undergoing AF ablation 
between 01/2014 and 09/2014 were included. Single TSP was performed in 202 (42%) 
patients, double TSP in 276 (58%) patients. Age, gender, body mass index, CHA2DS2-VASc 
score, left ventricular ejection fraction and operator experience (experienced operator defined 
as ≥ 5 years of experience in invasive electrophysiology) were equally distributed between the 
two groups. Repeat procedures (re-dos) were more frequently performed using single TSP 
access (p < 0.001). Left atrial (LA) diameter was larger in patients with double TSP (p = 
0.001). Procedure duration in single TSP was identical to double TSP procedures (p = 0.823). 
Radiation duration was similar between the two groups (p = 0.217). There were 49 (10%) 
  
patients with complications after catheter ablation. There were no differences between 
complication rates and TSP type (p = 0.555). Similarly, recurrence rates were comparable 
between both TSP groups (p = 0.788). 
Conclusion: There was no clear benefit of single or double TSP in AF ablation.  
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Transseptal puncture (TSP) is one of the most challenging steps in catheter ablation of 
atrial fibrillation (AF). It is a critical moment because of the potential risk of aortic puncture 
or puncture of the pericardial space. While single TSP reduces the risk associated with the 
puncture, double transseptal access simplifies the procedure in terms of immediate 
visualization of signals in the pulmonary vein, as well as avoidance of multiple changes of 
ablation and multipolar catheter through the single sheath.  
There are three options for transseptal access. First, the single transseptal approach 
strategy. Second, the single-puncture-double-transseptal approach with one puncture being 
performed and the second sheath/catheter being advanced in the left atrium (LA) beneath the 
first access site [1]. Thirdly, there is the option of double-puncture-double-transseptal access. 
Despite the great practical relevance, the impact of this decision by the operator is yet unclear 
— therefore, the aim of this study was to investigate whether single or double transseptal 
access is superior in terms of procedure time, radiation time, complication rates and outcome. 
 
Methods 
Consecutive patients admitted for ablation of AF were prospectively included in the 
AF ablation registry. The Leipzig AF Ablation Registry has been approved by the Ethics 
Authority. Data from patients between January 2014 and September 2014 were analyzed. The 
patients were ≥ 18 years old. Patients undergoing cryo-ablation and procedures with radiation-
saving technology (MediGuide, Abbott, St. Paul, MN, USA) were excluded to allow an 
unbiased comparison of the datasets. 
  
Baseline characteristics were analyzed, procedural aspects with a focus on procedure 
and fluoroscopy time, complication rates, and follow-up data are presented herein.  
 
Ablation procedure and TSP 
Indication for catheter ablation was based on the current European Society of 
Cardiology Guidelines [2]. Procedural steps have been described prior [3]. In brief, the 
patients were deeply sedated (midazolam, propofol) and received analgetics (fentanyl) as 
described by Kottkamp et al. [4]. Placement of the diagnostic right ventricular apex and 
coronary sinus catheter was performed via left femoral venous access. Invasive arterial 
monitoring was performed via left femoral artery. Sheaths for TSP were placed into the right 
femoral vein. The decision for single versus double TSP was at the operators’ discretion. 
In cases of a single TSP, the guide wire was advanced into the superior vena cava. The 
steerable sheath (Agilis, Abbott, St. Paul, MN, USA); the curve [S, M, L] of the sheath was 
selected on the basis of a previously performed cardiac magnetic resonance imaging [CMR]) 
was advanced into the superior vena cava, the wire was removed and the TSP needle was 
inserted. In a left anterior oblique (LAO) view, the steerable sheath was withdrawn until 
typically 2 “jumps” were observed. The position was confirmed in a right anterior oblique 
view (RAO). A small amount of contrast dye was injected to prove septal tenting in LAO. 
Then, the puncture was performed and documented with an X-Ray film. As soon as the needle 
was in the left atrium, the correct localization was confirmed by contrast dye injection and 
optionally by recording pressure via the needle tip. Subsequently, the steerable sheath was 
advanced into the LA, and the needle withdrawn. If a second TSP was planned, the same steps 
were performed with a non-steerable long sheath (SL 0, Abbott, St. Paul, MN, USA). 
An electroanatomical reconstruction of the LA was performed by use of a three-
dimensional (3D) mapping system (Carto 3, Biosense Webster, Diamond Bar, CA, USA; 
Ensite Velocity, Abbott, St. Paul, MN, USA), in a subgroup of these patients a fusion between 
the reconstructed 3D-CMR model and the electroanatomical reconstruction was done. 
Isolation of the pulmonary veins was confirmed by bidirectional block around the ipsilateral 
veins at an antral level. Linear lesions or focal ablations were added according to voltage 




Routine follow-up at the documented center included visits at 3, 6, and 9 months after 
ablation and then every 12 months thereafter [3]. Early recurrences within 3 months were 
considered as a blanking period. Atrial arrhythmias (≥ 30 s) were defined as recurrences. 
Usually, an electrocardiogram (ECG) was performed on each visit. If patients complained 
about symptoms, intensified resting and 1–7 days Holter-ECG-monitoring was performed. 
Only patients with at least one Holter-ECG or implantable device (pacemaker or ICD) and a 
follow-up of at least 6 months were included into the recurrence analysis.  
 
Complications 
Complications were classified into three groups: pericardial effusion (PE), groin 
complications and cerebrovascular incidents. PE was counted if relevant effusion was 
detected, puncture or operation was required. Groin complications were counted if a 
procedure (control, injection, stenting or operation) was required. The third category was 
cerebrovascular incidents including stroke and transient ischemic attack (TIA). 
 
Statistical analyses 
Mean values (and standard deviation [SD]) for normally distributed data, median (and 
interquartile range [IQR]) for skewed data and for categorical data proportions in percentage 
were used. The Spearman rank method was used for correlations. The unpaired t-test and  the 
Mann-Whitney test were used for differences in continuous variables and chi-square test for 
differences in categorical variables. Multivariable analysis (including variables with a p-value 
< 0.2 found on univariable analysis) was performed to find predictors for the complications. A 
p-value < 0.05 was defined as statistically significant. The statistical analyses were done with 
SPSS statistical software version 23 (SPSS Inc., Chicago, USA). 
 
Results 
The study included 478 patients undergoing radiofrequency AF catheter ablation 
between January and September 2014 at the Heart Center Leipzig (age 62 ± 10 years, 35% 
females, 67% persistent AF). The median follow-up was 23 months (IQR 4–37).  
Single TSP was performed in 202 (42%) patients, double TSP in 276 (58%) patients. Age, 
gender, body mass index and CHA2DS2-VASc score, left ventricular ejection fraction and 
operator experience (defined as ≥ 5 years of experience in invasive electrophysiology) were 
equally distributed between the two groups. Re-dos were more frequently performed using 
single TSP access (p < 0.001). LA diameter was larger in patients with double TSP (p = 
  
0.001). Procedure duration did not differ significantly between the two groups (p = 0.823). 
Radiation duration was similar for the two groups (p = 0.217), but the radiation dose was 
significantly lower in single TSP procedures (p < 0.001). TSP type did not affect the 
recurrence rate (p = 0.788) (Table 1, Fig. 3.) 
 
Complications 
There were 49 (10%) patients with clinically relevant complications. There were 25 
(5.2%) patients with pericardial effusion/tamponade, 19 (4.0%) with groin complications, and 
5 (1%) patients suffered stroke/TIA. There was no significant difference in total complication 
rates between single and double TSP (p=0.555), however, numerically there were less PE (10 
vs. 15), less groin complications (n=9 vs. n=10) and less strokes (n=1 vs. n=4) in the single 
TSP group (Table 2). Univariable analysis showed no significant association between age, 
gender of patient, AF type, LA size, CHA2DS2-VASc score, re-do procedures or operator 
experience on the complication rate (Table 3).  
 
Rhythm outcomes 
During follow-up, 195 patients (41%) received long-term monitoring with Holter-ECG 
or had an implantable device such as pacemaker/defibrillator allowing continuous monitoring 
and had a follow-up of 6 months or more. In this subgroup, there were 55 (71%) and 79 




Despite the large and growing number of AF ablations and the practical relevance to 
the question whether single or double TSP is better, there is, according to available research, 
no study comparing single versus double TSP for AF ablation procedures.  
The TSP is a crucial moment in the procedure of pulmonary vein isolation. 
Complications of TSP are puncture of the aorta and puncture of the posterior pericardial 
space. While in the SAFER Registry 0.9% PEs were described in all procedures [6], Haegeli 
et al. [7] showed, in double TSP procedures that there were 2.6% of pericardial effusions 
which required an intervention. Kastritsis et al. [8] have shown that TSP in AF ablation 
procedures are associated with a higher incidence of pericardial tamponade compared to TSP 
in other cardiac procedures. In the present study population, the overall rate of PE was 5%, 
  
but PE requiring an intervention was low with only 0.8%. This is likely due to the large 
experience at the documented center. 
The number of recurrences is high. However, because Holter monitoring was 
intensified in patients with symptoms and only those with Holter-ECG (or 
pacemaker/implantable cardioverter defibrillator [ICD]) were included in the analysis, the rate 
of recurrences is likely estimated too high. 
Some findings are interesting and the results need further explanations: for example, 
the finding that the x-ray time did not differ significantly between the two groups. Possibly, 
the higher radiation time which is needed for the second TSP in the double TSP group was 
compensated by the need for fluoroscopic control of the spiral and ablation catheter during the 
catheter exchange. That for each TSP an X-Ray film was recorded, was probably the reason 
for a higher radiation dose in the double TSP group. 
Secondly, the finding that single TSP only was more frequently performed in re-do 
procedures. This can be explained by the sometimes more challenging TSP because of an 
induration of the interatrial septum — therefore some operators may have skipped the initially 
planned second TSP. 
And thirdly, there were more double TSP in larger LA diameters. Probably, operators 
skipped the second TSP in small LA due to anticipation of negative effects of 2 transseptal 
sheaths in a small LA. Interestingly despite the fact that double TSP needs an additional 
access in the groin for a second sheath, an only statistically non-significant difference was 
observed in groin complication rate between the two groups.  
Silent cerebral events are more frequent in single transseptal access LA ablations, 
compared to double tansseptal access, due to the need for exchanging catheters over a single 
transseptal access as described by Deneke et al. [9]. In the current study, silent cerebral events 
were  not assessed , for instance by use of magnetic resonance imaging after ablation. 
Although double TSP was associated with more clinical cerebrovascular events compared to 
single TSP, the difference was not significant. Pathophysiologically, micro air-embolisms are 
most likely to be caused by catheter exchanges, while macro embolisms are usually caused by 
thrombi. This may explain the difference in the results. 
Overall, both approaches have advantages and disadvantages. The double TSP access 
has the advantage that one can simultaneously monitor the electrical signals in the pulmonary 
veins. Thus, the operator can often stop the ablation as soon as the signals in the pulmonary 
  
veins have disappeared. Furthermore, in linear lesions it is easier to check the lines by 
differential pacing. A single TSP requires more experience of the operator to promptly detect 
the signals in the pulmonary veins.. Here, the pace and ablate strategy was frequently used for 
verification before the ablation catheter is taken out and multipolar catheter (Lasso, Biosense 
Webster, Diamond Bar, CA, USA or Advisor, Abbott, St. Paul, MN, USA) is inserted. This is 
an excellent method because pacing to ensure unexcitability along ablation lines has 
demonstrated to improve outcomes compared with bidirectional block alone [10]. It might be 
expected that with continuous PV potential monitoring in double TSP, it is possible to reduce 
the duration of the procedure. On the other hand, the second TSP takes time. There was an 
inablity to show that ultimately, the procedure time tends to be shorter with double TSP. 
It should be mentioned that all double TSP were performed by double puncture. 
Single-puncture double-transseptal access is not performed at the documented center. 
However, the latter has been shown to be safe in previous studies [11]. 
 
Limitations of the study 
The main limitation of the study is that the decision on whether to use single or double 
TSP was at the operators’ discretion and not based on randomization. On the other hand, 369 
(77%) of the procedures were performed by operators who have ≥ 5 years invasive 
electrophysiological experience and thus the expertise was high and equally distributed 
between the two groups, reducing bias. It may be that in smaller LA, single TSP was preferred 
due to reasons of steerabilty.  
Another limitation is the lack of assessment of iatrogenic ASD (iASD) after the 
procedure. However, Hammerstingl et al. [12] reported that persistent iASD occurred after 
double access through one puncture in 8 out of 27 (30%) patients. The study of Rillig et al. 
[13] has shown 1 out of 31 (3%) patients have a persistent iASD 12 months after double TSP. 
Cryo-balloon PVI also often goes along with a persistent iASD because of the use of a 12 
French sheath (FlexCath Advance, Medtronic, Minneapolis, MN, USA) [14]. This sheath is 
larger than Agilis and SL 0 (8 and 7 French, Abbott, St. Paul, MN, USA). Nevertheless, 
iatrogenic ASD has not been found to lead to an increased risk of paradoxical embolism or 




In the present study, there was no inverse association of the operator experience and 
lower complication rates. This might be a result of the fact, that experienced operators 
performed more complex procedures. Female sex was not associated with higher 
complication rates as it is described in the literature [16–21]. This could be partly explained 
by a relatively small ablation cohort and a low number of complications. Neither was a higher 
CHA2DS2-VASc Score associated with higher complication rate. CHA2DS2-VASc score and 
early institutional experience showed a higher complication rate in the literature [19–22]. This 
was also attributed to the small sample size and low complication rate.  
 
Conclusions 
There was no clear benefit of single or double TSP in AF ablation. Recurrence and 
complication rate did not differ significantly. 
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Table 1. Clinical characteristics of the study population 
 Single TSP (n = 202) Double TSP (n = 276) P 
Age [years] 62 (55–71) 64 (57–71) 0.110 
Females, 79 (39%) 89 (32%) 0.131 
Persistent AF 138 (68%) 184 (67%) 0.762 
Re-ablation 75 (37%) 48 (17%) < 0.001 
BMI [kg/m2] 28 (25–32) 28 (26–32) 0.119 
CHA2DS2-VASc score 2 (1–3) 2 (1–3) 0.339 
LAd [mm] 43 (39–47) 45 (41–48) 0.001 
LVEF [%] 60 (55–64) 60 (51–64) 0.781 
Radiation time [min] 18.6 (11.5–25.5) 16.2 (10.1–25.0) 0.217 
Radiation dose [cGycm2] 3782 (1.800–7.200) 6200 (3.038–10.323) < 0.001 
Procedure time [min] 150 (120–180) 145 (120–175) 0.823 
Experienced operator 74% 79% 0.208 
Recurrences > 6 months* 55 (71%) 79 (69%) 0.788 
Complications 20 (10%) 29 (11%) 0.555 
*Recurrences > 6 months in patients with available implanted device (pacemaker, ICD, ILR) available in 193 
patients (40% of the study population). Data presented as number (%) or median (interquartile range); AF — 
atrial fibrillation; BMI — body-mass-index; LAd — left atrial diameter; LVEF — left ventricular ejection 
fraction; TSP — transseptal puncture 
 
  
Table 2. Complications accordingly to the transseptal puncture (TSP) type; p = 0.555 
 Total (n = 478) Single TSP (n = 202) Double TSP (n = 276) 
None 429 (89.6%) 182 (89.7%) 247 (89.5%) 
Pericardial effusion 25 (5.2%) 10 (4.9%) 15 (5.4%) 
Groin complications 19 (4.0%) 9 (4.4%) 10 (3.6%) 
Strokes 5 (1.0%) 1 (0.5%) 4 (1.4%) 
 
 
Table 3. Prediction of complications. 
 
CI — confidence interval; AF — atrial fibrillation; BMI — body mass index; TSP — transseptal puncture; LAd 
— left atrial diameter 
 
 
Figure 1. A. Left anterior oblique (LAO) 50° view. Single transseptal puncture; a — Agilis 
sheath (St. Jude, Abbott, St. Paul, MN, USA) in the left atrium with a 10 polar spiral-catheter 
in the left superior pulmonary vein; b — diagnostic catheter in the right ventricular apex; c — 
diagnostic catheter in the coronary sinus; d — temperature probe in esophagus; B. LAO 50° 
 Univariable analysis 
 Odds ratio (95% CI) P 
Age 1.034 (0.984–1.087) 0.187 
Females 2.124 (0.846–5.334) 0.109 
Persistent AF 1.059 (0.395–2.840) 0.910 
BMI [kg/m2] 0.957 (0.868–1.055) 0.376 
CHA2DS2-VASc score 1.240 (0.925–1.662) 0.151 
Re ablation of AF 1.035 (0.365–2.935) 0.948 
Experienced operator 1.602 (0.458–5.601) 0.461 
TSP type 1.623 (0.606–4.345) 0.335 
Procedure time [min] 1.006 (0.997–1.016) 0.171 
Radiation time [min] 1.013 (0.971–1.057) 0.551 
LAd [mm] 1.031 (0.958–1.109) 0.413 
  
view. Double transseptal puncture; a — SL0 Sheath (St. Jude, Abbott, St. Paul, MN, USA) in 
the left atrium with a 10 polar spiral-catheter in the left superior pulmonary vein; b — Agilis 
sheath  (St. Jude, Abbott, St. Paul, MN, USA) with ablation catheter ostial of the left superior 
pulmonary vein; c — diagnostic catheter in the right ventricular apex; d — diagnostic catheter 
in coronary sinus; e — temperature probe in the esophagus. 
 
Figure 2. I, II, V1, V6 = Surface-electrocardiogram, MAP = ablation catheter, Lasso 1–10 = 
10 polar spiral-catheter in the left superior pulmonary vein: a — farfield atrial signal; b — 
pulmonary vein signal; c — farfield ventricular signal; d — no pulmonary vein signal 
anymore; CS 1–10 — catheter in the coronary sinus; RVA — catheter in the right ventricular 
apex. The 10 polar spiral-catheter is placed in the left superior pulmonary vein. During 
ablation around the left superior pulmonary vein, the pulmonary vein, the pulmonary vein 
signal on the spiral-catheter disappears (b → d). This means that the vein was isolated, 
because there was hence, no signal passing the ablation line.  
 
Figure 3. A. Radiation dose in single and double transseptal puncture (TSP); B. Radiation 
time in single and double TSP; C. Recurrence in single and double TSP. 
 
 



